↗7 Form 4 rows in the window
Covers original filings from Jul 31, 2026 to Oct 28, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$7.4MSold on the market
1Companies
Oct 20, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 20, 202620:42 | Oct 20, 2026 | ORKAOruka Therapeutics, Inc. | General Counsel | S · Sell10b5-1 | $78.53 | −9,000 | 29,995 | -23% | −$707K | ||
| Oct 20, 202620:42 | Oct 20, 2026 | ORKAOruka Therapeutics, Inc. | General Counsel | M · Exercise10b5-1 | $7.80 | +9,000 | 38,995 | +30% | $70K | ||
| Sep 21, 202616:57 | Sep 21, 2026 | ORKAOruka Therapeutics, Inc. | General Counsel | S · Sell10b5-1 | $93.64 | −10,000 | 29,995 | -25% | −$936K | ||
| Sep 21, 202616:57 | Sep 21, 2026 | ORKAOruka Therapeutics, Inc. | General Counsel | M · Exercise10b5-1 | $7.80 | +10,000 | 39,995 | +33% | $78K | ||
| Sep 15, 202619:14 | Sep 15, 2026 | ORKAOruka Therapeutics, Inc. | General Counsel | S · Sell | $95.71 | −1,039 | 29,995 | -3% | −$99K | ||
| Aug 14, 202617:52 | Aug 14, 2026 | ORKAOruka Therapeutics, Inc. | General Counsel | S · Sell10b5-1 | $108.49 | −52,000 | 31,034 | -63% | −$5.6M | ||
| Aug 14, 202617:52 | Aug 14, 2026 | ORKAOruka Therapeutics, Inc. | General Counsel | M · Exercise10b5-1 | $11.60 | +52,000 | 83,034 | +168% | $603K |